Home › Kanser sa Suso › New York › Buffalo
Pag-aaral pangklinika para sa Kanser sa Suso sa Buffalo, NY
16 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Buffalo (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Roswell Park Cancer Institute, Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- Roswell Park Cancer Institute IDS, Buffalo
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Nagre-recruitPhase 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Nagre-recruitPhase 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
Nagre-recruit
- Roswell Park Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Nagre-recruitPhase 2
- Roswell Park Cancer Institute, Buffalo
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Nagre-recruitPhase 3
- Roswell Park Cancer Institute, Buffalo
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Nagre-recruitPhase 1/2
- Roswell Park Cancer Institute, Buffalo
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Nagre-recruit
- Buffalo General Medical Center, Buffalo
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Nagre-recruit
- Roswell Park Comprehensive Cancer Center, Buffalo
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
Nagre-recruit
- Roswell Park Cancer Institute, Buffalo
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Nagre-recruitObservasyonal na pag-aaral
- Roswell Park Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Buffalo
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Nagre-recruitObservasyonal na pag-aaral
- Roswell Park Cancer Institute, Buffalo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Buffalo
- Non-Small Cell Lung Cancer19 pag-aaral
- Kanser (lahat ng uri)19 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Kanser sa Baga16 pag-aaral
- Kanser sa Ovary13 pag-aaral
- Metastatic Cancer11 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Melanoma10 pag-aaral
- Multiple Myeloma10 pag-aaral
- Obesity9 pag-aaral
- Burkitt Lymphoma8 pag-aaral
- Myelodysplastic Syndromes8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.